Fig 1: Dual modulation of Aβ42 production by GSAP-16K. (A) GSAP-16K exhibits dual modulation on Aβ42 production. Aβ42 production peaks in the presence of 3 μM GSAP-16K. One-way ANOVA was used to analyze the statistical significance compared with that in the absence of GSAP-16K. If not specified, one-way ANOVA was applied for statistical analysis. (B) Aβ40 production decreases in the presence of 3 μM or more GSAP-16K. (C) The combined production of Aβ42 and Aβ40 exhibits a bell-shaped curve with respect to the total concentration of GSAP-16K. (D) The Aβ42/Aβ40 ratio is elevated proportionally in the GSAP-16K concentration range of 0 to 3 μM. Aβ40 and Aβ42 were quantified using the AlphaLISA kit (33). Each experiment was independently repeated three times. Error bar: SD. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns: no significant.
Fig 2: PTH‐induced Notch1 pathway activation by regulating GSAP. (A) The site prediction of miR‐29a‐5p with GSAP. (B) The dual‐luciferase assay miR‐29a‐5p with GSAP. n = 10 per group. *** P < .01 vs mimics‐NC group. (C, D) The protein level of GSAP in groups of HUVECs and CKD rats respectively. (E) The level of γ‐secretase in the CTL, PTH, PTH+PTHrP(7‐34), PTH+miR‐29a‐mimics and PTH+si‐GSAP groups. (F, G) The protein level of NICD and Hes1 and in the CTL, PTH, PTH+miR‐29a‐5p‐mimics, PTH+miR‐NC, PTH+NS and PTH+si‐GSAP groups. (H, I) Fluorescence staining of Hes1. (J) The pattern diagram of Notch1 signal activation regulated by miR‐29a‐5p/GSAP. (C‐H) Data were presented as the mean ± SD. n = 4 per group. ** P < .01 vs CTL group. *** P < .001 vs CTL group. #P < .01 vs PTH group. ##P < .01 vs PTH group. ###P < .001 vs PTH group
Fig 3: A working model of γ-secretase modulation by GSAP-16K. (A) GSAP-16K (residues 734 to 758) and AICD (residues 730 to 738) form a stable complex. Shown here are representative chromatographs of gel filtration (Left) and western blots of the indicated fractions from gel filtration (Right). UV, ultraviolet. (B) The AICD fragment that binds GSAP-16K is located five residues downstream of the induced β-strand from APP-C99. Cleavage between Leu720 and Val721 of APP-C99 by γ-secretase generates Aβ49 (Asp672 through Leu720) and AICD (Val721 through Asn770). (C) A mechanistic model of γ-secretase modulation by GSAP-16K through LLPS. In the absence of GSAP-16K, the recruitment of APP-C99 into γ-secretase favors the production of Aβ49, which is successively processed into Aβ40. GSAP-16K in dilute phase promotes the production of Aβ48, which is processed into Aβ42 (21). GSAP-16K condensates, and droplets sequester APP-C99, making the substrate inaccessible to γ-secretase. PS1 CTF: PS1 C-terminal fragment; PS1 NTF: PS1 N-terminal fragment.
Fig 4: AICD is incorporated into the GSAP-16K droplets in vitro. (A) GST-AICD colocalizes with the GSAP-16K puncta-like condensates and droplets in vitro. Alexa488-labeled GST-AICD at the indicated concentrations was incubated with 40 μM Alexa647-labeled GSAP-16K in the absence of PEG for 1 h (first three columns). The white arrow indicates the position of line scans (refer to SI Appendix, Fig. S4C). GST-AICD alone fails to form condensates/droplets (fourth column). (B) GST does not colocalize with GSAP-16K puncta-like condensates and droplets. (C) AICD can be incorporated into preformed GSAP-16K condensates/droplets. Shown here are temporal snapshots of AICD incorporation into preformed GSAP-16K droplets. The first snapshot (0 min) was taken less than 1 min after adding 5 μM AICD to the preformed GSAP-16K droplets.
Fig 5: GSAP-16K undergoes LLPS in vitro. (A) Recombinant GSAP-16K protein forms droplets preferentially in the presence of high-molecular mass PEG. GSAP-16K at 10 μM was incubated with 10% (wt/vol) PEG of varying molecular mass. All images in this study were taken using a confocal laser scanning microscope unless otherwise stated. (B) Higher concentrations of GSAP-16K and lower ionic strengths favor droplet formation. Five concentrations of GSAP-16 were evaluated for droplet formation under five distinct ionic strengths in the presence of 10% (wt/vol) PEG8000. (C) Fusion of two neighboring GSAP-16K droplets. GSAP-16K at 10 μM was monitored in the presence of 10% PEG 8000. (D) The GSAP-16K droplets show FRAP. Four temporal snapshots of a representative GSAP-16K droplet are shown in Left. Quantitative analysis, averaged for the results of FRAP on three different droplets, is shown in Right. Error bar: SD. (E) Formation of GSAP-16K puncta-like condensates and droplets in the absence of PEG. Three concentrations of GSAP-16K were evaluated for LLPS under four distinct ionic strengths in the absence of PEG.
Supplier Page from Abcam for Anti-GSAP antibody